Stocks / Pharmaceuticals
ZVRAPharmaceuticals
Zevra Therapeutics, Inc.
$12.011d +1.8%5d -0.4%settled close · 2026-09-17
Mkt cap $537M (3/25)β 0.7552w $9.50–14.75Shares 58.7MInd. Pharmaceutical PreparationsNasdaq since 2015Emp. 61HQ Boston, MAzevra.com
Who’s talkingIdea Scout · free
Who’s talking about ZVRA
No tracked investor commentary on ZVRA yet — the corpus grows weekly.
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
Earnings
Next report: 3 Nov 2026
Confirmed date · consensus EPS 0.16. Reactions below are the next settled session over the prior close.
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where ZVRA’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 11 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-08-06 | ||||||
| 2026-08-05 | ||||||
| 2026-08-04 | ||||||
| 2026-08-03 | ||||||
| 2026-07-31 | ||||||
| 2026-07-30 | ||||||
| 2026-07-29 | ||||||
| 2026-07-28 | ||||||
| 2026-07-24 | ||||||
| 2026-06-18 | ||||||
| 2026-06-09 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
ZVRA is in this morning’s Brief.
Get The Brief — $20/mo →